Abnormal Glucose Regulation Is Associated With Lipid-Rich Coronary Plaque Relationship to Insulin Resistance

被引:64
作者
Amano, Tetsuya [1 ]
Matsubara, Tatsuaki [2 ]
Uetani, Tadayuki
Nanki, Michio
Marui, Nobuyuki
Kato, Masataka
Yoshida, Tomohiro
Arai, Kosuke
Yokoi, Kiminobu
Ando, Hirohiko
Kumagai, Soichiro
Ishii, Hideki [3 ]
Izawa, Hideo [3 ]
Hotta, Nigishi
Murohara, Toyoaki [3 ]
机构
[1] Chubu Rosai Hosp, Dept Cardiol, Minato Ku, Nagoya, Aichi 4558530, Japan
[2] Aichi Gakuin Univ, Sch Dent, Dept Internal Med, Nagoya, Aichi 464, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan
关键词
D O I
10.1016/j.jcmg.2007.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to determine lipid and fibrous volume of coronary atherosclerotic plaques in subjects with abnormal glucose regulation (AGR) by integrated backscatter (IB) intravascular ultrasound (IVUS) during percutaneous coronary intervention. BACKGROUND Abnormal glucose regulation, including impaired glucose regulation (IGR) and diabetes mellitus (DM), has emerged as an important determinant of cardiovascular risk. We hypothesized that AGR would be associated with coronary plaque instability. METHODS Conventional intravascular ultrasound and IB-IVUS using a 40-MHz (motorized pullback 1 mm/s) intravascular catheter was performed in 172 consecutive patients. The percentage of fibrous area and the percentage of lipid area were automatically calculated by IB-IVUS. Three-dimensional analysis of IB-IVUS images was performed to determine the percentage of lipid volume (%LV) and fibrous volume (%FV). Following the World Health Organization criteria, the subjects were classified into the DM group, the IGR group, and the normal glucose regulation group. The cutoff point for the lipid-rich plaque was defined as %LV>44% or %FV <52%, which was the 75th percentile of %LV or the 25th percentile of %FV in this study population. Insulin resistance (IR) was defined as the homeostasis model assessment of insulin resistance (HOMA-IR). RESULTS There were no significant differences in the baseline characteristics except for glucometabolic parameters. The conventional IVUS analysis indicated that the DM group had a significantly increased plaque volume (and percent plaque volume). In the IB-IVUS analysis, as compared with the normal glucose regulation group, the DM and the IGR groups showed a significant increase in %LV (36 +/- 14% and 37 +/- 13% vs. 29 +/- 14%, p = 0.02) and a significant decrease in %FV (59 +/- 11% and 58 +/- 11% vs. 64 +/- 11%, p = 0.03). The lipid-rich plaque rate was significantly associated with an increasing HOMA-IR in the tertile (p = 0.008). On logistic regression analysis after adjusting for confounding and coronary risk factors, the DM group (odds ratio 3.52, 95% confidence interval 1.13 to 11.0, p = 0.03) and the IGR group (odds ratio 3.92, 95% confidence interval 1.13 to 13.6, p = 0.03) were significantly associated with the lipid-rich plaque. CONCLUSIONS Coronary lesions in patients with AGR are associated with more lipid-rich plaque content, which may be related to the increased IR in these patients. (J Am Coll Cardiol Img 2008;1:39-45) (C) 2008 by the American College of Cardiology Foundation
引用
收藏
页码:39 / 45
页数:7
相关论文
共 26 条
[1]   Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions - Integrated backscatter intravascular ultrasound study [J].
Amano, Tetsuya ;
Matsubara, Tatsuaki ;
Uetani, Tadayuki ;
Nanki, Michio ;
Marui, Nobuyuki ;
Kato, Masataka ;
Arai, Kosuke ;
Yokoi, Kiminobu ;
Ando, Hirohiko ;
Ishii, Hideki ;
Izawa, Hideo ;
Murohara, Toyoaki .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (11) :1149-1156
[2]   ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE AND THE DEVELOPMENT OF MYOCARDIAL-INFARCTION [J].
AMBROSE, JA ;
TANNENBAUM, MA ;
ALEXOPOULOS, D ;
HJEMDAHLMONSEN, CE ;
LEAVY, J ;
WEISS, M ;
BORRICO, S ;
GORLIN, R ;
FUSTER, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (01) :56-62
[3]   METABOLIC AND GENETIC-CHARACTERIZATION OF PREDIABETIC STATES - SEQUENCE OF EVENTS LEADING TO NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BECKNIELSEN, H ;
GROOP, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :1714-1721
[4]   Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M ;
Willeit, J .
DIABETOLOGIA, 2000, 43 (02) :156-164
[5]   Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria [J].
Borch-Johnsen, K ;
Neil, A ;
Balkau, B ;
Larsen, S ;
Nissinen, A ;
Pekkanen, J ;
Tuomilehto, J ;
Jousilahti, P ;
Lindstrom, J ;
Pyörälä, M ;
Pyörälä, K ;
Eschwege, E ;
Gallus, G ;
Garancini, MP ;
Bouter, LM ;
Dekker, JM ;
Heine, RJ ;
Nijpels, HG ;
Stehouwer, CDA ;
Feskens, EJM ;
Kromhout, D ;
Peltonen, M ;
Pajak, A ;
Eriksson, J ;
Qiao, Q .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :397-405
[6]   Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association [J].
Buse, John B. ;
Ginsberg, Henry N. ;
Bakris, George L. ;
Clark, Nathaniel G. ;
Costa, Fernando ;
Eckel, Robert ;
Fonseca, Vivian ;
Gerstein, Hertzel C. ;
Grundy, Scott ;
Nesto, Richard W. ;
Pignone, Michael P. ;
Plutzky, Jorge ;
Porte, Daniel ;
Redberg, Rita ;
Stitzel, Kimberly F. ;
Stone, Neil J. .
CIRCULATION, 2007, 115 (01) :114-126
[7]   The relationship between glucose and incident cardiovascular events [J].
Coutinho, M ;
Gerstein, HC ;
Wang, Y ;
Yusuf, S .
DIABETES CARE, 1999, 22 (02) :233-240
[8]   Development and progression of atherosclerotic disease in relation to insulin resistance and hyperinsulinemia [J].
Fujiwara, T ;
Saitoh, S ;
Takagi, S ;
Takeuchi, H ;
Isobe, T ;
Chiba, Y ;
Miura, T ;
Shimamoto, K .
HYPERTENSION RESEARCH, 2005, 28 (08) :665-670
[9]   CARDIOVASCULAR RISK-FACTORS IN CONFIRMED PREDIABETIC INDIVIDUALS - DOES THE CLOCK FOR CORONARY HEART-DISEASE START TICKING BEFORE THE ONSET OF CLINICAL DIABETES [J].
HAFFNER, SM ;
STERN, MP ;
HAZUDA, HP ;
MITCHELL, BD ;
PATTERSON, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (21) :2893-2898
[10]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234